Articles About NYSE:GSK
March 04, 2014
GlaxoSmithKline stock has trended higher in recent years but is currently trading sideways.
March 03, 2014
GlaxoSmithKline has put a hold on two clinical studies of an experimental drug to treat ulcerative colitis and lupus.
March 02, 2014
GlaxoSmithKline's CEO received a smaller bonus in 2013 due to the aftermath an ongoing Chinese investigation into bribery allegations against the company.
February 21, 2014
GlaxoSmithKline is urging the European Commission to label e-cigarettes as medicine and increase regulation on the products.
February 06, 2014
GlaxoSmithKline stock has trended higher in recent years.
February 03, 2014
GlaxoSmithKline has won "breakthrough therapy" status for another of its drugs in development, Promacta/Revolade.
January 24, 2014
GlaxoSmithKline's diabetes drug, which is being marketed under the name Eperzan, has won a recommendation for approval from the European Medicines Agency.
January 15, 2014
GlaxoSmithKline stock has trended higher in recent years and is currently trading near highs for the year.
January 13, 2014
GlaxoSmithKline has handed back its rights to drisapersen, a drug in late-stage development for the treatment of Duchenne muscular dystrophy, to Prosensa.